Role of cell cycle inhibitors in adult neural stem cells

细胞周期抑制剂在成体神经干细胞中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Although stem cell therapy has been proposed for repair, still relatively little is known about the behavior of these cells in the adult injured CNS. It is well accepted that two major mitogens for adult SVZ cells have very different effects on their behavior: FGF2 increases proliferation and favors neurogenesis (Kuhn et al., 1997), while EGF increases proliferation at the expenses of neurogenesis (Doetsch et al., 2002), but the downstream signaling pathways remain elusive. This proposal tests the hypothesis that p27Kip1 and p53, two crucial cell cycle regulators which are expressed in the adult SVZ and often mutated in glioblastomas, are downstream effectors of signaling pathways activated by FGF2 and EGF in SVZ cells. This hypothesis is based on genetic evidence derived from the phenotypic characterization of p27Kip1-/- and in p53-/- mice, conducted in our laboratory and indicating a close similarity between the phenotype of p53-/- mice and FGF2 injection, and that of p27Kip1-/- mice and EGF injection. We further propose, based on the results of our proteomic and gene profiling studies, a molecular mechanism integrating these two cell cycle genes within downstream signaling networks that modulate lineage determination and survival. Therefore, this proposal addresses novel molecular mechanisms for the role of the cell cycle molecules p27Kip1 and p53 in modulating not only proliferation, but also survival and lineage specification of adult progenitors and neural stem cells residing in the adult subventricular zone (SVZ). Specific aim 1 tests the hypothesis that cell cycle regulation of slow and fast-proliferating cells in the adult SVZ is differentially modulated by p27Kip1 and p53 and that these molecules are downstream of FGF2 and EGF. Specific aim 2 tests the hypothesis that the opposing role of FGF2 and EGF on adult neurogenesis is dependent on their effect on p53 and p27Kip1 which play antagonistic roles on molecular networks affecting cell fate determination. Specific aim 3 will test the hypothesis that p53 and p27Kip1 exert antagonistic functions on apoptotic pathways in adult SVZ cells. The results of the proposed studies will significantly extend our current knowledge on the mechanisms of cell division and neoplastic transformation of adult SVZ cells. In addition, by addressing novel and unexplored roles for p27Kip and p53 as part of transcriptional networks and signaling pathways, they will also significantly impact several other fields, including developmental neurobiology and clinical neurobiology.
描述(由申请人提供):尽管干细胞疗法已被提议用于修复,但对于这些细胞在成人受伤中枢神经系统中的行为仍然知之甚少。人们普遍认为,成年 SVZ 细胞的两种主要有丝分裂原对其行为具有截然不同的影响:FGF2 增加增殖并有利于神经发生(Kuhn 等,1997),而 EGF 增加增殖但牺牲神经发生(Doetsch 等,2002),但下游信号通路仍然难以捉摸。该提案测试了以下假设:p27Kip1 和 p53(在成人 SVZ 中表达并经常在胶质母细胞瘤中突变的两种关键细胞周期调节因子)是 SVZ 细胞中 FGF2 和 EGF 激活的信号通路的下游效应器。这一假设基于我们实验室进行的 p27Kip1-/- 和 p53-/- 小鼠表型特征的遗传证据,表明 p53-/- 小鼠和 FGF2 注射的表型与 p27Kip1-/- 小鼠和 EGF 注射的表型非常相似。根据我们的蛋白质组学和基因分析研究的结果,我们进一步提出了一种将这两个细胞周期基因整合到调节谱系决定和存活的下游信号网络中的分子机制。因此,该提案提出了细胞周期分子 p27Kip1 和 p53 的作用的新分子机制,不仅调节增殖,而且调节位于成体室下区 (SVZ) 的成体祖细胞和神经干细胞的存活和谱系规范。具体目标 1 检验以下假设:成人 SVZ 中缓慢和快速增殖细胞的细胞周期调节受到 p27Kip1 和 p53 的差异调节,并且这些分子是 FGF2 和 EGF 的下游。具体目标 2 测试了以下假设:FGF2 和 EGF 对成体神经发生的相反作用取决于它们对 p53 和 p27Kip1 的影响,而 p53 和 p27Kip1 在影响细胞命运决定的分子网络上发挥拮抗作用。具体目标 3 将检验 p53 和 p27Kip1 对成年 SVZ 细胞的凋亡途径发挥拮抗功能的假设。所提出的研究结果将显着扩展我们目前对成体 SVZ 细胞分裂和肿瘤转化机制的认识。此外,通过解决 p27Kip 和 p53 作为转录网络和信号通路一部分的新的和未探索的作用,它们还将对其他几个领域产生重大影响,包括发育神经生物学和临床神经生物学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patrizia Casaccia其他文献

Patrizia Casaccia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patrizia Casaccia', 18)}}的其他基金

Environmental Biosensors in the Oligodendrocyte Lineage
少突胶质细胞谱系中的环境生物传感器
  • 批准号:
    10613458
  • 财政年份:
    2019
  • 资助金额:
    $ 1.36万
  • 项目类别:
Environmental biosensors in the oligodendrocyte lineage
少突胶质细胞谱系中的环境生物传感器
  • 批准号:
    10397521
  • 财政年份:
    2019
  • 资助金额:
    $ 1.36万
  • 项目类别:
Histone Deacetylation in Oligodendrocyte Differentiation
少突胶质细胞分化中的组蛋白脱乙酰化
  • 批准号:
    9551145
  • 财政年份:
    2017
  • 资助金额:
    $ 1.36万
  • 项目类别:
2018 Myelin Gordon Research Conference and Gordon Research Seminar
2018年髓磷脂戈登研究会议暨戈登研究研讨会
  • 批准号:
    9471150
  • 财政年份:
    2017
  • 资助金额:
    $ 1.36万
  • 项目类别:
Molecular Mechanism of Neuronal Damage in Demyelinating Disorders
脱髓鞘疾病神经元损伤的分子机制
  • 批准号:
    8645765
  • 财政年份:
    2011
  • 资助金额:
    $ 1.36万
  • 项目类别:
Molecular Mechanism of Neuronal Damage in Demyelinating Disorders
脱髓鞘疾病神经元损伤的分子机制
  • 批准号:
    8470259
  • 财政年份:
    2011
  • 资助金额:
    $ 1.36万
  • 项目类别:
Molecular Mechanism of Neuronal Damage in Demyelinating Disorders
脱髓鞘疾病神经元损伤的分子机制
  • 批准号:
    8129856
  • 财政年份:
    2011
  • 资助金额:
    $ 1.36万
  • 项目类别:
Molecular Mechanism of Neuronal Damage in Demyelinating Disorders
脱髓鞘疾病神经元损伤的分子机制
  • 批准号:
    8231373
  • 财政年份:
    2011
  • 资助金额:
    $ 1.36万
  • 项目类别:
Role of cell cycle inhibitors in adult neural stem cells
细胞周期抑制剂在成体神经干细胞中的作用
  • 批准号:
    7773512
  • 财政年份:
    2007
  • 资助金额:
    $ 1.36万
  • 项目类别:
Role of cell cycle regulators in differentiation
细胞周期调节因子在分化中的作用
  • 批准号:
    8427335
  • 财政年份:
    2007
  • 资助金额:
    $ 1.36万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 1.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了